CD

Chandrakala Devi

Active Director Additional Director DIN 11383839
DIN 11383839 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrakala Devi

Data last updated:

Chandrakala Devi is an Additional Director at Zodichem Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11383839
Primary Designation Additional Director
Industry Pharma
First Appointment 15 Nov 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director15 Nov 20252024Active

Board colleagues of Chandrakala Devi

Directorship timeline

Open interactive timeline →
Zodichem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandrakala Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakala Devi

Chandrakala Devi currently holds 1 directorship: Zodichem Pharmaceuticals Private Limited (Additional Director, since 15 Nov 2025).

Chandrakala Devi was first appointed on 15 Nov 2025 as Additional Director at Zodichem Pharmaceuticals Private Limited.

The current boards of Chandrakala Devi's companies include Baban Singh (Zodichem Pharmaceuticals Private Limited), Bablu Chauhan (Zodichem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available